Scott Pain

Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials

Emmanuel Mignot, David Mayleben, Ingo Fietze et al. · The Lancet Neurology · 2022 · 234 citations

Medicine, Pharmacology, Pharmacotherapy +10

Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)

Julie Bernhardt, Leonid Churilov, Fiona Ellery et al. · Neurology · 2016 · 217 citations · Full text

Medicine, Rehabilitation Medicine, Geriatric Rehabilitation +14

Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder

Yves Dauvilliers, Gary Zammit, Ingo Fietze et al. · Annals of Neurology · 2020 · 142 citations

Medicine, Pharmacology, Pharmacotherapy +17

Daridorexant, a new dual orexin receptor antagonist, in elderly subjects with insomnia disorder

Gary Zammit, Yves Dauvilliers, Scott Pain et al. · Neurology · 2020 · 101 citations

Medicine, Pharmacology, Pharmacotherapy +17

Phase 1/1<scp>B</scp> trial of the heat shock protein 90 inhibitor <scp>NVP</scp>‐<scp>AUY</scp>922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma

Ruth Seggewiß-Bernhardt, Ralf C. Bargou, Yeow Tee Goh et al. · Cancer · 2015 · 72 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14